updated 1/24/2007 2:48:05 PM ET 2007-01-24T19:48:05

The Food and Drug Administration has ended an investigation into a broker offering ready-made embryos to prospective parents, concluding the agency had no jurisdiction.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

The FDA has not disclosed what laws or regulations were the focus of the investigation into Jennalee Ryan’s Abraham Center of Life. The agency’s statement Wednesday said “the investigation determined the facility was not currently engaged in practices that fall under FDA jurisdiction.”

Ryan’s service involves a physician who uses donated eggs and sperm to create embryos that cost $5,000 a pair. Clients can review the donors’ characteristics, including their ethnic and educational background and, in some cases, their photos.

Some critics have said Ryan’s business may be crossing ethical lines by marketing a better baby.

But Ryan said she’s just trying to help couples or single women, for example, who may not be able to have a biological baby.

© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments